Dariusz Chrostowski, MD
Allergy · Watertown, NYNPI 1922100247
Payments from drug & device makers
Across 602 payments — averaging $1248.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$327K
- Astrazeneca UK Limited$290K
- Eli Lilly$102K
- Dermavant Sciences, Inc.$10K
- Teva Pharmaceuticals USA, Inc.$7K
- Pfizer$6K
- plus $9K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 151 | $327,277 |
| Astrazeneca UK Limited | 5 | $290,139 |
| Eli Lilly | 10 | $102,265 |
| Dermavant Sciences, Inc. | 44 | $10,117 |
| Teva Pharmaceuticals USA, Inc. | 14 | $7,052 |
| Pfizer | 32 | $5,888 |
| GSK | 105 | $1,879 |
| Sanofi | 34 | $1,467 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $816 |
| Regeneron Healthcare Solutions, Inc. | 25 | $670 |
| Grifols USA, LLC | 25 | $603 |
| CSL Behring | 27 | $580 |
| Amgen(2 entities) | 14 | $449 |
| Genentech USA, Inc. | 14 | $297 |
| Biocryst US Sales Co., LLC | 13 | $295 |
| Novartis | 15 | $293 |
| Pharming Healthcare, Inc. | 8 | $263 |
| Optinose US, Inc. | 12 | $230 |
| Aimmune Therapeutics, Inc. | 6 | $138 |
| Boehringer Ingelheim | 7 | $105 |
| Shire North American Group Inc | 2 | $93 |
| Jubilant Hollisterstier LLC | 1 | $90 |
| Bio Products Laboratory USA, Inc. | 3 | $67 |
| Kaleo, Inc. | 3 | $66 |
| Lilly USA, LLC | 2 | $53 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $41 |
| Merck | 2 | $36 |
| Ionis Pharmaceuticals, Inc. | 1 | $29 |
How this compares
$751,298 in reported general payments places this provider in the 95th percentile of 92 allergy providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy in Watertown
- Christopher SmithHorseheads$18M
- Marc BraunsteinHewlett$924K
- Allison RamseyRochester$904K
- Anne MaitlandTarrytown$626K
- Yudhistira PersaudBronx$280K
- Alan KaufmanMount Vernon$227K
- Michael KatlanAlbany$91K
- Michel AklJamestown$90K
- Juan SotomayorNorth Syracuse$64K
- Rachel MillerNew York$56K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.